Table 2.
Control | α-T | δ-T | γ-T | γ-TmT | |
---|---|---|---|---|---|
Apoptotic Markers | |||||
BAX | 1.0 ± 0.1 | 1.2 ± 0.1 | 1.4 ± 0.1 | 1.5 ± 0.1 | 1.4 ± 0.2 |
Bcl2 | 1.0 ± 0.2 | 0.5 ± 0.1b | 0.6 ± 0.1a | 0.6 ± 0.1a | 0.4 ± 0.1b |
XIAP | 1.0 ± 0.4 | 0.8 ± 0.1 | 0.8 ± 0.1 | 0.8 ± 0.1 | 0.8 ± 0.1 |
Cell Proliferation, Survival, and Cycle | |||||
PCNA | 1.0 ± 0.1 | 1.0 ± 0.1 | 0.9 ± 0.1 | 0.7 ± 0.1 | 0.7± 0.1 |
PKCα | 1.0 ± 0.3 | 1.1 ± 0.1 | 0.8 ± 0.1 | 0.8 ± 0.1 | 0.9 ± 0.2 |
PTEN | 1.0 ± 0.1 | 1.4 ± 0.2 | 2.0 ± 0.4a | 2.1 ± 0.3a | 1.6 ± 0.3a |
Myc | 1.0 ± 0.2 | 0.7 ± 0.2 | 0.9 ± 0.1 | 0.6 ± 0.1 | 0.7 ± 0.1 |
p53 | 1.0 ± 0.1 | 1.0 ± 0.1 | 1.0 ± 0.1 | 0.8 ± 0.1 | 1.1 ± 0.2 |
p21 | 1.0 ± 0.1 | 1.2 ± 0.1 | 1.3 ± 0.1a | 1.4 ± 0.1a | 1.5 ± 0.2a |
p27 | 1.0 ± 0.3 | 1.8 ± 0.2a | 2.0 ± 0.4a | 2.1 ± 0.3b | 2.5 ± 0.3c |
Cyclin D1 | 1.0 ± 0.2 | 1.2 ± 0.3 | 1.0 ± 0.3 | 0.5 ± 0.1 | 0.7 ± 0.3 |
Nuclear Receptors | |||||
ERα | 1.0 ± 0.1 | 0.9 ± 0.2 | 0.6 ± 0.0a | 0.7 ± 0.1 | 0.5 ± 0.1a |
ERβ | 1.0 ± 0.1 | 0.7 ± 0.2 | 0.6 ± 0.1 | 0.8 ± 0.2 | 0.7 ± 0.2 |
PPARγ | 1.0 ± 0.1 | 1.5 ± 0.3 | 1.8 ± 0.2a | 2.1 ± 0.2b | 1.9 ± 0.1a |
Nrf2 Pathway | |||||
Nrf2 | 1.0 ± 0.1 | 1.0 ± 0.1 | 0.9 ± 0.1 | 1.1 ± 0.1 | 0.8 ± 0.1 |
Keap1 | 1.0 ± 0.1 | 1.0 ± 0.1 | 1.0 ± 0.1 | 0.9 ± 0.1 | 1.0 ± 0.1 |
Phase II Detoxifying Enzymes | |||||
NQO1 | 1.0 ± 0.1 | 1.3 ± 0.1 | 1.2 ± 0.1 | 1.3 ± 0.2 | 1.4 ± 0.1 |
GClm | 1.0 ± 0.3 | 2.8 ± 0.9a | 2.5 ± 0.2a | 2.8 ± 0.5a | 2.9 ± 0.4a |
GSTm1 | 1.0 ± 0.1 | 1.6 ± 0.2a | 1.5 ± 0.1a | 1.7 ± 0.1a | 2.0 ± 0.5a |
Ugt1A1 | 1.0 ± 0.1 | 1.8 ± 0.3b | 1.7 ± 0.2a | 1.7 ± 0.2a | 1.8 ± 0.4a |
COMT | 1.0 ± 0.1 | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.9 ± 0.1 | 1.2 ± 0.3 |
Antioxidant Enzymes | |||||
SOD1 | 1.0 ± 0.1 | 1.3 ± 0.2 | 1.2 ± 0.1 | 1.2 ± 0.2 | 1.4 ± 0.2 |
HO-1 | 1.0 ± 0.1 | 1.3 ± 0.2 | 1.4 ± 0.3 | 1.3 ± 0.1 | 1.2 ± 0.1 |
GPx | 1.0 ± 0.1 | 1.4 ± 0.1 | 1.2 ± 0.1 | 1.6 ± 0.2a | 1.5 ± 0.2 |
TXN1 | 1.0 ± 0.1 | 1.0 ± 0.1 | 1.3 ± 0.2 | 1.3 ± 0.2 | 1.3 ± 0.2 |
Catalase | 1.0 ± 0.1 | 1.2 ± 0.1 | 0.9 ± 0.1 | 0.9 ± 0.1 | 1.0 ± 0.1 |
NMU-treated Sprague-Dawley rats were administered 0.3% α-, δ-, γ-tocopherol (T), or γ-TmT in the diet. A mammary tumor from each rat was analyzed for mRNA levels by quantitative PCR and normalized by GAPDH. The values (fold-induction) are represented as mean ± S.E (n=6-8 per group);
p<0.05,
p<0.01,
p<0.001.